載入...
The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma
Melanoma is one of the most fatal and therapy-resistant types of cancer; therefore, identifying novel therapeutic candidates to improve patient survival is an ongoing effort. Previous studies have revealed that pimozide is not sufficient to treat melanoma; therefore, enhancing the treatment is neces...
Na minha lista:
| 發表在: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065445/ https://ncbi.nlm.nih.gov/pubmed/30015838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4473 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|